•

Peter Agre, Nobel Laureate & Vice Chancellor for Science and Technology, Duke Univ.

•

Richard Axel, Nobel Laureate & University Professor, Columbia University; Investigator, HHMI

•

Lee Babiss, Global Head, Pharma Research, Roche Pharmaceuticals

•

David Baltimore, Nobel Laureate & former President, Caltech

•

Etienne-Emile Baulieu, former President, French Academy of Sciences

•

Eleanor Baum, Dean, School of Engineering, The Cooper Union for the Advancement of Science and Art

•

Paul Berg, Nobel Laureate & Professor Emeritus, Dept. of Biochemistry, Stanford University

•

Len Blavatnik, Chairman, Access Industries

•

Günter Blobel, Nobel Laureate & Director, Laboratory for Cell Biology, Rockefeller University

•

Christian Brechot, Director General, INSERM, France

•

Sydney Brenner, Nobel Laureate & Distinguished Professor, Salk Institute

•

Michael S. Brown, Nobel Laureate & Professor of Molecular Genetics, University of Texas Southwestern Medical Center

•

Linda Buck, Nobel Laureate & Investigator for Howard Hughes Medical Institute; Member of the Fred Hutchinson Cancer Research Center

•

Karen E. Burke, Dermatologist and Research Scientist

•

Thomas R. Cech, Nobel Laureate & President, Howard Hughes Medical Institute

•

Ceclia Chan, Vice Chairman, Immtech Pharmaceuticals, Inc.

•

Aaron J. Ciechanover , Nobel Laureate & Distinguished Research Professor, Tumor and Vascular Biology Research Center, Faculty of Medicine, Technion-Israel Inst. of Tech., Haifa, Israel

•

Gordon Conway, Chief Science Advisor, UK Department for International Development

•

Peter Doherty, Nobel Laureate & Researcher, St. Jude Children's Research Hospital, Memphis, TN; Univ. of Melbourne

•

Frank L. Douglas, Executive-in-Residence, MIT Sloan School of Management; former Executive Vice President, Aventis

•

Edmond H. Fischer, Ph.D, Nobel Laureate & Professor Emeritus, Department of Bio Chemistry, Univ. of Washington

•

Richard N. Foster, Millbrook Management Group, LLC

•

Claire M. Fraser-Liggett, Director, Univ. of Maryland School of Medicine

•

Alan J. Friedman, former Director, New York Hall of Science

•

Jean-Pierre Garnier, Chief Executive Officer, GlaxoSmithKline, UK

•

Colin Goddard, Chief Executive Officer, OSI Pharmaceuticals

•

Joseph Goldstein, Nobel Laureate & Chairman, Dept. of Molecular Genetics, University of Texas Southwestern Medical Center

•

Paul Greengard, Nobel Laureate & Professor of Molecular & Cellular Neuroscience, Rockefeller University

•

Peter Gruss, President, Max Planck Gesellschaft, Germany

•

William A. Haseltine, President, The Haseltine Foundation for Medical Sciences and the Arts; Chairman, Haseltine Global Health, LLC

•

Eric Kandel, Nobel Laureate & Professor, Physiology and Cell Biology, Columbia University

•

Kiyoshi Kurokawa, Science Advisor to the Prime Minister of Japan; Adjunct Professor, RCAST, The University of Tokyo; Professor, Research Institute of Science and Technology, Tokai University

•

Leon Lederman, Nobel Laureate & Pritzker Prof. of Science, Illinois Inst. of Tech.; Resident Scholar, Illinois Math & Science Academy

•

Roderick MacKinnon, Nobel Laureate & John D. Rockefeller, Jr. Prof., Rockefeller Univ.; Investigator, HHMI

•

Joel S. Marcus, Chief Executive Officer, Alexandria Real Estate Equities, Inc.

•

Gerald J. McDougall, National Partner, Global Pharmaceutical & Health Sciences Practice, PricewaterhouseCoopers LLP

•

Richard Menschel, Senior Director, Goldman Sachs

•

Ronay Menschel, Chairman of the Board, Phipps Houses; Board of Overseers, Weill Cornell Medical College

•

John F. Niblack, former President, Pfizer Global Research & Development

•

Jean-Marc Neimetz, Vice President, Global Life Science Group, Capgemini

•

Paul Nurse, Nobel Laureate & President, Rockefeller Univ

•

Robert C. Richardson, , Nobel Laureate & Senior Vice Provost for Research, Floyd R. Newman Prof. of Physics, Cornell Univ.

•

Peter Ringrose, Chairman, Biotechnology & Biological Sciences Research Council, UK; former CSO, Bristol-Myers Squibb

•

Edward F. Rover, President, The Dana Foundation

•

F. Sherwood Rowland, Nobel Laureate & Prof. of Chemistry & Earth Science, Univ. of California, Irvine

•

Bengt Samuelsson, Nobel Laureate & Prof., Medical & Physiological Chem., Karolinska Inst.; former Chairman, The Nobel Foundation

•

Charles Sanders, former President, GlaxoSmithKline

•

Ismail Serageldin, Librarian of Alexandria, Director of the Bibliotheca Alexandria, The Library of Alexandria, Egypt

•

Phillip A. Sharp, Nobel Laureate & Director, The McGovern Inst., MIT Center for Cancer Research

•

Elliott Sigal, Chief Scientific Officer, Bristol-Myers Squibb

•

Michael Sohlman, Executive Director, Nobel Foundation

•

Paul Stoffels, Company Group Chairman, World Wide Research & Development, Pharmaceuticals Group, Johnson & Johnson

•

Mary Ann Tighe, Chief Executive Officer, New York Tri-State Region, C B Richard Ellis

•

Shirley Tilghman, President, Princeton University

•

Harold Varmus, Nobel Laureate & President & CEO, Memorial Sloan-Kettering Cancer Center

•

Frank Walsh, Executive Vice President, Discovery Research, Wyeth Research

•

Gerald Weissmann, Professor of Medicine, New York University School of Medicine

•

John Whitehead, former Chairman, Lower Manhattan Development Corp.; former Co-Chairman of Goldman Sachs

•

George Whitesides, Mallinckrodt Prof. of Chemistry, Harvard Univ.

•

Torsten N. Wiesel, Nobel Laureate & Honorary Life Governor, New York Academy of Sciences; Secretary General, Human Frontier Science Program Organization; President Emeritus, Rockefeller Univ.

•

Frank Wilczek, Nobel Laureate & Herman Feshbach Professor of Physics, MIT

•

Ernst-Ludwig Winnacker, Secretary General, European Research Council; former President, Deutsche Forschungsgemeinschaft, Germany

•

Guangzhao Zhou, former Chairman, Chinese Association of Science & Technology